The North America Clinical Trials Market plays a central role in global drug development, driving advancements in healthcare and pharmaceuticals across the region. In 2024, the market reached a valuation of USD 35.31 billion and is projected to expand at a CAGR of 6.00%, reaching USD 63.23 billion by 2034. This growth reflects ongoing innovation in trial methodologies, regulatory support, and...